CLINICAL_TRIALS
trial_result
· 2019-05-13
Clinical Trial Update: MINI-AMI: Minimizing Infarct Size With Impella 2.5 Following PCI for Acute Myocardial Infarction [NA]
Summary
A terminated clinical trial evaluating Impella 2.5 to minimize infarct size after PCI in ST-elevation myocardial infarction (STEMI).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abiomed Inc. | Conditions: ST-elevation Myocardial Infarction | NA | Status: TERMINATED | Results posted: 2019-05-13